In this review, we summarize current knowledge on CAF biology, outline their mechanistic contribution to tumor progression, and provide a clinically oriented survey of CAF-directed therapeutic strategies, including, but not limited to, FAP-targeted imaging, radioligand therapy, and stromal modulation. This evidence concerns the gene FAP and neoplasm.